Ligand Reports First Quarter 2025 Financial Results
Go back to Ligand Reports First Quarter 2025 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 309.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $309.25 | 52 Week High | $139.79 | |||
| Open | $309.25 | 52 Week Low | $82.07 | |||
| Day High | $309.25 | P/E | 719.19 | |||
| Day Low | $309.25 | EPS | $0.43 | |||
| Volume | 1,434 | |||||
| (NASDAQ: VRNA) | Delayed: 106.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $106.91 | 52 Week High | $ | |||
| Open | $106.91 | 52 Week Low | $ | |||
| Day High | $106.91 | P/E | N/A | |||
| Day Low | $106.91 | EPS | $ | |||
| Volume | 11,101 | |||||
